Who Paid My Doc
Kedrab
Biological Infectious Disease
NDC 76125-150-02
General payments
$371,289
Research payments
$0
Through program year 2025, $371,289 in general payments and $0 in research payments were reported against Kedrab (Infectious Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $87,891 | 763 |
| 2024 | General | $96,478 | 861 |
| 2023 | General | $65,574 | 189 |
| 2022 | General | $17,614 | 71 |
| 2021 | General | $98,636 | 64 |
| 2020 | General | $2,950 | 10 |
| 2019 | General | $2,146 | 82 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 73 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
2,040 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.